Targeting MMP13 has been shown to reduce the invasion and growth of cSCC in mice [55, 58] but further work is required to establish whether increased MMP13 levels are associated with cSCC that develop in KS patients. This evidence concerns the gene MMP13 and Kindler syndrome.